QuickView for ADORA1;jsessionid=2111B80A389BE5054565A651D218425B;jsessionid=8611FF944CF8280ACD767ADB7D9F4401;jsessionid=6775219B978B1AA22B9EEC33E3343AC4;jsessionid=3AF55DA2B8ECBA56C8C627D5B0D9A315;jsessionid=2F8F1E92667D4E603FDEC12283AE5D64;jsessionid=62B974341D8A59D4E142C835CF1718F7;jsessionid=99EF30D19C7F1ECCCB344500661BB5AF;jsessionid=BA0F1C5D46C45B029416E858A468895A;jsessionid=51D289477660E66DBD5F088E5A339266 (gene)

1. Caffeine Impaired Acupuncture Analgesia in Inflammatory Pain by Blocking Adenosine A1 Receptor.
2. Ex Vivo Feedback Control of Neurotransmission Using a Photocaged Adenosine A1 Receptor Agonist.
3. Lack of efficacy of a partial adenosine A1 receptor agonist in neuropathic pain models in mice.
4. Dopamine Release in Nucleus Accumbens Is under Tonic Inhibition by Adenosine A1 Receptors Regulated …
5. The role of adenosine A1 receptor agonist in adenosine augmentation therapy for patients with refrac…

There were no clinical trials for ADORA1;jsessionid=2111B80A389BE5054565A651D218425B;jsessionid=8611FF944CF8280ACD767ADB7D9F4401;jsessionid=6775219B978B1AA22B9EEC33E3343AC4;jsessionid=3AF55DA2B8ECBA56C8C627D5B0D9A315;jsessionid=2F8F1E92667D4E603FDEC12283AE5D64;jsessionid=62B974341D8A59D4E142C835CF1718F7;jsessionid=99EF30D19C7F1ECCCB344500661BB5AF;jsessionid=BA0F1C5D46C45B029416E858A468895A;jsessionid=51D289477660E66DBD5F088E5A339266